4 ms·
Because they benefit from the massive amount spent on medical innovation in the U.S.
by whitepoplar 9y ago
Because they benefit from the massive amount spent on medical innovation in the U.S.
- rootusrootus 9y agoThen maybe it's time we renegotiated that deal so other countries (esp wealthy ones) pulled their weight.
- whitepoplar 9y agoAgreed!
- dagw 9y agoWho's "we" and what would that look like? We're talking largely about private companies operating in a global market (esp. when dealing with wealthy countries). If a US buyer is willing to buy $1000 and a UK buyer says we're not paying more than $100, should the pharmaceutical company be banned from selling to the UK at that price? No one is forcing the pharmaceutical companies to sell to UK here. If they feel it's in their interest to accept the $100 then surely they should be free to do so.